MusthInsider

Latest On Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Updated on: March 19, 2021

Date/Time	Type	Description	Signal
2023-05-12 21:12 EST	News	Biohaven Non-GAAP EPS of -$0.98	N/A
2023-03-24 07:34 EST	News	Biohaven Non-GAAP EPS of -$1.27 beats by $0.01	N/A
2023-03-22 08:38 EST	News	Biohaven acquires rights to potential brain disorder drug BHV-8000 for $10M upfront	N/A
2023-03-10 05:36 EST	News	Biohaven: Spun And Done - Time To Exit	N/A
2023-02-21 22:11 EST	News	Biohaven's spinal muscular atrophy therapy gets FDA fast track status	N/A
2023-01-04 17:02 EST	News	Biohaven initiated at overweight at JP Morgan on neurological targets	N/A
2022-12-08 04:49 EST	News	Biohaven Ltd: Assessing The Spinoff	N/A
2022-11-09 21:19 EST	News	Biohaven Non-GAAP EPS of -$1.25	N/A
2022-10-21 04:41 EST	News	Biohaven prices upsized 25M of stock offering at $10.50/share	N/A
2022-10-18 16:23 EST	News	Biohaven stock falls 5% after the bell on 20M share offering	N/A
2022-10-07 13:52 EST	News	Biotech in recovery; but Piper Sandler cites negative fund flows	N/A
2022-10-07 13:49 EST	News	M&A may be a tailwind for biotech sector into end of year, analyst says	N/A
2022-10-07 13:40 EST	News	'New' Biohaven up 81% days after Pfizer acquisition as investors see pipeline potential	N/A
2022-10-06 23:49 EST	News	Biohaven Stub May Provide An Interesting Setup For Investors	N/A
2022-09-29 23:19 EST	News	Biohaven says ALS candidate failed in key trial	N/A
2022-09-28 00:37 EST	News	Pfizer acquisition of Biohaven Pharmaceuticals expected to close Oct. 3	N/A
2022-09-19 19:50 EST	News	Biohaven announces timeline for spinoff	N/A
2022-08-17 15:12 EST	News	Biohaven: Non-Standard Merger Consideration Makes This A Buy	N/A
2022-08-16 05:06 EST	News	Soros Fund Management takes new stakes in GCP, Biohaven, Tesla	N/A
2022-08-05 15:33 EST	News	Biohaven Pharmaceuticals Non-GAAP EPS of -$3.82 misses by $1.57, revenue of $194M misses by $16.6M	N/A
2022-07-07 09:59 EST	News	Biohaven begins enrolling in late-stage trial of spinal muscular atrophy therapy	N/A
2022-06-15 23:08 EST	News	Biohaven Deal: Pfizer Gives Away A Freeroll	N/A
2022-06-01 11:56 EST	News	Federal Trade Commission to hold pharma merger and antitrust workshop	N/A
2022-05-23 14:53 EST	News	Biohaven phase 3 trial in genetic muscle disorder fails to reach significance overall due to low disease progression	N/A
2022-05-23 14:53 EST	News	Biohaven gets FDA review for nasal spray zavegepant to treat migraine	N/A
2022-05-11 01:00 EST	News	Biohaven Pharmaceuticals Non-GAAP EPS of -$1.62 beats by $0.65, revenue of $318.85M beats by $135.14M	N/A
2022-05-11 01:00 EST	News	Pfizer to acquire Biohaven in ~$11.6B deal; Biohaven stock soars 72%	N/A
2022-05-06 21:00 EST	News	Biohaven Pharmaceuticals Q1 2022 Earnings Preview	N/A
2022-04-27 19:21 EST	News	Pfizer, Biohaven's Vydura gets approval in EU to prevent/treat migraine	N/A
2022-04-14 05:28 EST	News	Biohaven Pharmaceutical: Recent Growth Will Continue	N/A
2022-02-26 00:18 EST	News	Biohaven Pharmaceuticals Non-GAAP EPS of -$2.32 misses by $0.39, revenue of $190.01M beats by $14.47M	N/A
2022-02-26 00:18 EST	News	Biohaven in licensing pact with Bristol Myers; to acquire Channel Biosciences	N/A
2022-02-26 00:18 EST	News	Pfizer, Biohaven's rimegepant gets EMA panel nod for migraine treatment	N/A
2022-02-26 00:18 EST	News	Biohaven Pharmaceutical Holding Company Ltd. 2021 Q4 - Results - Earnings Call Presentation	N/A
2022-02-26 00:17 EST	News	Biohaven Pharmaceutical Holding's (BHVN) CEO Vlad Coric on Q4 2021 Results - Earnings Call Transcript	N/A
2022-02-25 05:15 EST	News	Biohaven Pharmaceuticals Q4 2021 Earnings Preview	N/A
2022-02-22 19:32 EST	News	Biohaven begins enrollment in phase 2/3 trial of Nurtec ODT in chronic rhinosinusitis	N/A
2022-02-15 01:21 EST	News	Pfizer/ Biohaven announce late-stage migraine trial met main goals in Asia Pacific	N/A
2022-02-01 23:30 EST	News	New thematic psychedelic ETF hits the market	N/A
2022-01-28 21:24 EST	News	Aurinia Pharmaceuticals quick uptick on renewed takeover speculation on Biogen news	N/A
2022-01-18 18:11 EST	News	Biohaven’s Troriluzole to undergo glioblastoma trial designed to study multiple therapies	N/A
2022-01-14 05:01 EST	News	Aurinia Pharmaceuticals reverses decline after report on potential M&A interest	N/A
2022-01-10 16:33 EST	News	Biohaven forms research collaboration to advance TRPM3 antagonists for pain management	N/A
2022-01-06 09:41 EST	News	Biohaven reports preliminary Q4 Nurtec ODT revenue of $190M	N/A
2021-12-07 06:52 EST	News	Biohaven names Vlad Coric as Chairman, appoints new CFO	N/A
2021-12-06 12:13 EST	News	Biohaven says pivotal study for intranasal migraine therapy met main goals	N/A
2021-12-06 12:13 EST	News	Biohaven names new CEO, CFO	N/A
2021-11-18 11:13 EST	News	Biohaven, Artizan to work on Parkinson's drug discovery program	N/A
2021-11-17 13:22 EST	News	Biohaven's migraine med Nurtec approved in Kuwait	N/A
2021-11-10 03:44 EST	News	Pfizer to gain ex-U.S. rights to Biohaven migraine med Nurtec in up to $1.24B deal	N/A

About Biohaven Pharmaceutical Holding Company Ltd (BHVN):

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological diseases and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as id developing Rimegepant for preventive treatment of migraine and other non-migraine indications; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole, which is in phase III clinical trials for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 that is in phase I clinical trial for neuropsychiatric indications; and Verdiperstat, a product that is in phase III trial for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

See Advanced Chart

General

Name Biohaven Pharmaceutical Holding Company Ltd
Symbol BHVN
Type Common Stock
Exchange NYSE
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 825
Fiscal Year EndDecember
IPO Date2017-05-04
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://www.biohavenpharma.com

Valuation

Price/Sales (Trailing 12 Mt.) 71.25
Price/Book (Most Recent Quarter) 31.82
Enterprise Value Revenue 73.75

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$10.49
Next Year EPS Estimate -$5.57
Next Quarter EPS Estimate -$2.73
Operating Margin -1014%
Return on Assets -78%
Revenue 63.63 million
Earnings Per Share -$9.14
Revenue Per Share $1.08
Gross Profit 45.93 million
Quarterly Earnings Growth 0%

Highlights

Market Capitalization 4.42 billion
EBITDA -356321504
Analyst Target Price $102.09
Book Value Per Share $2.09

Share Statistics

Shares Outstanding 61.93 million
Shares Float 54.37 million
% Held by Insiders 1379%
% Held by Institutions 117.55%
Shares Short 5.76 million
Shares Short Prior Month 5.98 million
Short Ratio 11.39
Short % of Float 13%
Short % of Shares Outstanding 9%

Technicals

Beta 1.08
52 Week High $100.77
52 Week Low $28.26
50 Day Moving Average 82.8
200 Day Moving Average 80.62

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-01	$N/A	-$2.69	-$2.56	-4.98%
2020-09-30	2020-11-09	$17.66 million	-$2.67	-$2.86	6.58%
2020-06-30	2020-08-10	$9.7 million	-$2.55	-$2.84	10.27%
2020-03-31	2020-05-07	$1.15 million	-$2.39	-$2.46	2.94%
2019-12-31	2020-02-25	$N/A	-$2.85	-$1.91	-49.31%
2019-09-30	2019-11-01	$N/A	-$2.04	-$1.57	-30.24%
2019-06-30	2019-08-08	$N/A	-$4.67	-$2.09	-123.21%
2019-03-31	2019-05-07	$N/A	-$1.41	-$1.50	5.94%
2018-12-31	2019-02-28	$N/A	-$1.33	-$1.21	-10.12%
2018-09-30	2018-11-14	$N/A	-$1.53	-$1.08	-42.33%
2018-06-30	2018-08-14	$N/A	-$1.01	-$1.05	3.68%
2018-03-31	2018-05-15	$N/A	-$2.32	-$1.17	-98.29%
2017-12-31	2018-03-06	$N/A	-$0.75	-$1.35	44.34%
2017-09-30	2017-11-14	$N/A	-$1.19	-$1.24	3.78%
2017-06-30	2017-08-14	$N/A	-$1.78	-$0.62	-185.94%
2017-03-31	2017-06-16	$N/A	-$1.74	-$1.45	-20%

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Chart:

Biohaven Pharmaceutical Holding Company Ltd (BHVN) News:

Below you will find a list of latest news for Biohaven Pharmaceutical Holding Company Ltd (BHVN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2026-02-20	1	0	CALL	0	0	0	TRUE	0	0
2026-02-20	2	0	CALL	0	0	599.28	TRUE	0	0
2026-02-20	3	0	CALL	0	0	456.17	TRUE	0	0
2026-02-20	4	0	CALL	0	0	360.21	TRUE	0	0
2026-02-20	5	4.55	CALL	0	0	287.74	TRUE	0	0
2026-02-20	6	0	CALL	0	0	288.8	TRUE	0	0
2026-02-20	7	4	CALL	3	39	193.21	TRUE	4	0
2026-02-20	8	0	CALL	0	0	135.25	TRUE	0	0
2026-02-20	9	3.1	CALL	0	6	108.67	TRUE	0	0
2026-02-20	10	1.15	CALL	0	20	205.38	TRUE	0	0
2026-02-20	11	1	CALL	0	906	77.53	FALSE	0	0
2026-02-20	12	0.3	CALL	10	1649	82.8	FALSE	-0.2	-0.4
2026-02-20	13	0.24	CALL	1	1311	101.79	FALSE	-0.01	-0.04
2026-02-20	14	0.15	CALL	1	1042	107.69	FALSE	0	0
2026-02-20	15	0.1	CALL	25	1463	114	FALSE	0	0
2026-02-20	16	0.1	CALL	0	285	206.33	FALSE	0	0
2026-02-20	17	0.25	CALL	0	235	170.02	FALSE	0	0
2026-02-20	18	0.1	CALL	0	32	195.39	FALSE	0	0
2026-02-20	19	0.29	CALL	0	24	255.19	FALSE	0	0
2026-02-20	20	0.1	CALL	0	20	180.74	FALSE	0	0
2026-02-20	21	0.2	CALL	0	18	281.76	FALSE	0	0
2026-02-20	22	0.33	CALL	0	1	265.99	FALSE	0	0
2026-02-20	1	0.05	PUT	0	1	645.7	FALSE	0	0
2026-02-20	2	0	PUT	0	0	450.59	FALSE	0	0
2026-02-20	3	0	PUT	0	0	432.69	FALSE	0	0
2026-02-20	4	0	PUT	0	0	488.48	FALSE	0	0
2026-02-20	5	0.25	PUT	0	1	248.43	FALSE	0	0
2026-02-20	6	0.04	PUT	0	2	169.86	FALSE	0	0
2026-02-20	7	0.02	PUT	0	169	255.61	FALSE	0	0
2026-02-20	8	0.04	PUT	0	126	114.15	FALSE	0	0
2026-02-20	9	0.1	PUT	0	120	141.13	FALSE	0	0
2026-02-20	10	0.35	PUT	6	2279	79.58	FALSE	0.04	0.13
2026-02-20	11	0.6	PUT	20	663	77.55	TRUE	-0.1	-0.14
2026-02-20	12	1.6	PUT	6	383	92.72	TRUE	0.07	0.05
2026-02-20	13	2.25	PUT	0	105	70.27	TRUE	0	0
2026-02-20	14	1.65	PUT	0	106	0	TRUE	0	0
2026-02-20	15	4.05	PUT	0	83	0	TRUE	0	0
2026-02-20	16	0	PUT	0	0	0	TRUE	0	0
2026-02-20	17	0	PUT	0	0	0	TRUE	0	0
2026-02-20	18	0	PUT	0	0	0	TRUE	0	0
2026-02-20	19	0	PUT	0	0	225.52	TRUE	0	0
2026-02-20	20	0	PUT	0	0	0	TRUE	0	0
2026-02-20	21	0	PUT	0	0	0	TRUE	0	0
2026-02-20	22	0	PUT	0	0	0	TRUE	0	0
2026-03-20	3	0	CALL	0	0	246.26	TRUE	0	0
2026-03-20	4	0	CALL	0	0	209.8	TRUE	0	0
2026-03-20	5	0	CALL	0	0	152.96	TRUE	0	0
2026-03-20	6	0	CALL	0	0	151.69	TRUE	0	0
2026-03-20	7	0	CALL	0	0	187.76	TRUE	0	0
2026-03-20	8	5.3	CALL	0	6	189.55	TRUE	0	0
2026-03-20	9	0	CALL	0	0	137.7	TRUE	0	0
2026-03-20	10	2.04	CALL	0	1	145.99	TRUE	0	0
2026-03-20	11	1.58	CALL	0	2	137.12	FALSE	0	0
2026-03-20	12	1	CALL	0	10	103.5	FALSE	0	0
2026-03-20	13	1	CALL	3	66	117.9	FALSE	1	0
2026-03-20	14	0.78	CALL	0	37	145.02	FALSE	0	0
2026-03-20	15	0.6	CALL	8	278	118.03	FALSE	0.6	0
2026-03-20	16	0.76	CALL	0	3	107.27	FALSE	0	0
2026-03-20	17	0.65	CALL	0	59	122.37	FALSE	0	0
2026-03-20	18	0.95	CALL	0	1	282.06	FALSE	0	0
2026-03-20	19	0	CALL	0	0	264.85	FALSE	0	0
2026-03-20	20	0.35	CALL	0	1	270.7	FALSE	0	0
2026-03-20	3	0	PUT	0	0	233.54	FALSE	0	0
2026-03-20	4	0	PUT	0	0	289.18	FALSE	0	0
2026-03-20	5	0	PUT	0	0	233.46	FALSE	0	0
2026-03-20	6	0	PUT	0	0	189.02	FALSE	0	0
2026-03-20	7	0	PUT	0	0	151.61	FALSE	0	0
2026-03-20	8	0.38	PUT	0	1	107.88	FALSE	0	0
2026-03-20	9	0.49	PUT	0	19	103.94	FALSE	0	0
2026-03-20	10	0.99	PUT	0	92	100.18	FALSE	0	0
2026-03-20	11	1.58	PUT	4	175	99.93	TRUE	1.58	0
2026-03-20	12	2.28	PUT	0	42	115.89	TRUE	0	0
2026-03-20	13	2	PUT	0	59	102.53	TRUE	0	0
2026-03-20	14	0	PUT	0	0	113.11	TRUE	0	0
2026-03-20	15	4.32	PUT	0	5	114.94	TRUE	0	0
2026-03-20	16	0	PUT	0	0	118.1	TRUE	0	0
2026-03-20	17	0	PUT	0	0	146.56	TRUE	0	0
2026-03-20	18	0	PUT	0	0	78.68	TRUE	0	0
2026-03-20	19	0	PUT	0	0	0	TRUE	0	0
2026-03-20	20	0	PUT	0	0	0	TRUE	0	0
2026-04-17	1	0	CALL	0	0	401.85	TRUE	0	0
2026-04-17	2.5	9.69	CALL	0	36	234.73	TRUE	0	0
2026-04-17	4	0	CALL	0	0	183.11	TRUE	0	0
2026-04-17	5	7.2	CALL	0	49	154.09	TRUE	0	0
2026-04-17	6	0	CALL	0	0	204.09	TRUE	0	0
2026-04-17	7.5	6.14	CALL	0	308	141.72	TRUE	0	0
2026-04-17	9	4.74	CALL	0	763	138.17	TRUE	0	0
2026-04-17	10	3.05	CALL	0	584	120.05	TRUE	0	0
2026-04-17	11	4.2	CALL	0	45	120.93	FALSE	0	0
2026-04-17	12.5	1.75	CALL	131	996	123.81	FALSE	0.25	0.17
2026-04-17	14	1.3	CALL	0	213	115.11	FALSE	0	0
2026-04-17	15	1.02	CALL	52	2534	116.41	FALSE	-0.15	-0.13
2026-04-17	16	1.02	CALL	0	92	128.07	FALSE	0	0
2026-04-17	17.5	0.85	CALL	1	1023	129.19	FALSE	0.85	0
2026-04-17	19	1.19	CALL	0	17	116.58	FALSE	0	0
2026-04-17	20	0.46	CALL	125	157	119.82	FALSE	0.46	0
2026-04-17	21	0.65	CALL	0	16	150.15	FALSE	0	0
2026-04-17	22.5	0.45	CALL	0	805	126.41	FALSE	0	0
2026-04-17	25	0.55	CALL	0	135	153.02	FALSE	0	0
2026-04-17	27.5	0.5	CALL	0	143	137.86	FALSE	0	0
2026-04-17	30	0.35	CALL	0	173	168.81	FALSE	0	0
2026-04-17	32.5	0.55	CALL	0	172	177.17	FALSE	0	0
2026-04-17	35	0.2	CALL	0	1014	184.75	FALSE	0	0
2026-04-17	1	0	PUT	0	0	297.52	FALSE	0	0
2026-04-17	2.5	0.25	PUT	0	16	206.91	FALSE	0	0
2026-04-17	4	0	PUT	0	0	180.74	FALSE	0	0
2026-04-17	5	0.15	PUT	0	142	182.18	FALSE	0	0
2026-04-17	6	0.27	PUT	0	8	147.59	FALSE	0	0
2026-04-17	7.5	0.4	PUT	0	459	114.06	FALSE	0	0
2026-04-17	9	0.75	PUT	0	20	106.02	FALSE	0	0
2026-04-17	10	1.7	PUT	5	350	115.85	FALSE	0.15	0.1
2026-04-17	11	1.77	PUT	0	67	158.44	TRUE	0	0
2026-04-17	12.5	2.86	PUT	0	150	108.7	TRUE	0	0
2026-04-17	14	3.3	PUT	0	152	112.1	TRUE	0	0
2026-04-17	15	4.2	PUT	0	185	112.31	TRUE	0	0
2026-04-17	16	6	PUT	0	19	119.45	TRUE	0	0
2026-04-17	17.5	5.7	PUT	0	32	120.08	TRUE	0	0
2026-04-17	19	0	PUT	0	0	128.01	TRUE	0	0
2026-04-17	20	9.6	PUT	0	8	119.74	TRUE	0	0
2026-04-17	21	0	PUT	0	0	117.06	TRUE	0	0
2026-04-17	22.5	11.1	PUT	0	6	114.73	TRUE	0	0
2026-04-17	25	0	PUT	0	0	0	TRUE	0	0
2026-04-17	27.5	16.4	PUT	0	20	0	TRUE	0	0
2026-04-17	30	17.86	PUT	0	1	0	TRUE	0	0
2026-04-17	32.5	18.8	PUT	0	28	148.22	TRUE	0	0
2026-04-17	35	23.7	PUT	0	3	0	TRUE	0	0
2026-07-17	1	0	CALL	0	0	174.23	TRUE	0	0
2026-07-17	2.5	0	CALL	0	0	172.7	TRUE	0	0
2026-07-17	4	0	CALL	0	0	203.09	TRUE	0	0
2026-07-17	5	5.7	CALL	0	2	178.94	TRUE	0	0
2026-07-17	6	8.31	CALL	0	41	149.23	TRUE	0	0
2026-07-17	7.5	4.91	CALL	0	20	132.99	TRUE	0	0
2026-07-17	9	0	CALL	0	0	127.15	TRUE	0	0
2026-07-17	10	3.3	CALL	0	71	126.85	TRUE	0	0
2026-07-17	11	4.5	CALL	0	2	95.05	FALSE	0	0
2026-07-17	12.5	3	CALL	1	1430	108.95	FALSE	0.37	0.14
2026-07-17	14	2.4	CALL	0	81	108.67	FALSE	0	0
2026-07-17	15	1.7	CALL	0	489	108.59	FALSE	0	0
2026-07-17	16	3.1	CALL	0	2	111.11	FALSE	0	0
2026-07-17	17.5	1.75	CALL	0	133	110.36	FALSE	0	0
2026-07-17	19	2.85	CALL	0	47	107.99	FALSE	0	0
2026-07-17	20	2.2	CALL	0	17	107.81	FALSE	0	0
2026-07-17	21	1.2	CALL	5	273	115.05	FALSE	1.2	0
2026-07-17	1	0	PUT	0	0	228.49	FALSE	0	0
2026-07-17	2.5	0	PUT	0	0	162.39	FALSE	0	0
2026-07-17	4	0	PUT	0	0	150.39	FALSE	0	0
2026-07-17	5	0.55	PUT	0	2	112.43	FALSE	0	0
2026-07-17	6	0	PUT	0	0	149.35	FALSE	0	0
2026-07-17	7.5	1.05	PUT	0	48	103.51	FALSE	0	0
2026-07-17	9	0	PUT	0	0	110.81	FALSE	0	0
2026-07-17	10	2.51	PUT	0	114	106.3	FALSE	0	0
2026-07-17	11	2.75	PUT	0	7	105.9	TRUE	0	0
2026-07-17	12.5	4	PUT	1	14	104.89	TRUE	4	0
2026-07-17	14	0	PUT	0	0	106.94	TRUE	0	0
2026-07-17	15	5	PUT	0	107	104.52	TRUE	0	0
2026-07-17	16	5.2	PUT	0	100	104.63	TRUE	0	0
2026-07-17	17.5	0	PUT	0	0	121.41	TRUE	0	0
2026-07-17	19	9.2	PUT	0	50	91.19	TRUE	0	0
2026-07-17	20	0	PUT	0	0	91.48	TRUE	0	0
2026-07-17	21	9.8	PUT	0	4	113.2	TRUE	0	0
2026-12-18	2.5	9	CALL	0	35	133.55	TRUE	0	0
2026-12-18	5	7.1	CALL	0	30	77.34	TRUE	0	0
2026-12-18	7.5	5	CALL	0	77	98.76	TRUE	0	0
2026-12-18	10	5.74	CALL	0	254	99.45	TRUE	0	0
2026-12-18	12.5	5.07	CALL	0	66	101.98	FALSE	0	0
2026-12-18	15	3.87	CALL	0	589	119.01	FALSE	0	0
2026-12-18	17.5	3.3	CALL	0	45	108.9	FALSE	0	0
2026-12-18	20	4.8	CALL	0	673	120.09	FALSE	0	0
2026-12-18	22.5	5	CALL	0	11	114.01	FALSE	0	0
2026-12-18	25	2.94	CALL	0	233	105.07	FALSE	0	0
2026-12-18	27.5	0	CALL	0	0	121.19	FALSE	0	0
2026-12-18	30	1.6	CALL	1	12	113.65	FALSE	1.6	0
2026-12-18	32.5	1.5	CALL	0	1	129.44	FALSE	0	0
2026-12-18	35	1.45	CALL	0	54	133.51	FALSE	0	0
2026-12-18	37.5	0	CALL	0	0	135.91	FALSE	0	0
2026-12-18	40	1.25	CALL	0	4	139.31	FALSE	0	0
2026-12-18	42.5	1.25	CALL	0	1	142.45	FALSE	0	0
2026-12-18	45	1.9	CALL	0	37	145.37	FALSE	0	0
2026-12-18	47.5	0	CALL	0	2	146.75	FALSE	0	0
2026-12-18	50	1	CALL	0	11	149.3	FALSE	0	0
2026-12-18	52.5	2.75	CALL	0	9	151.69	FALSE	0	0
2026-12-18	55	3.33	CALL	0	2	153.95	FALSE	0	0
2026-12-18	57.5	0	CALL	0	0	156.08	FALSE	0	0
2026-12-18	60	1.05	CALL	0	15	206.08	FALSE	0	0
2026-12-18	65	0.59	CALL	0	37	197.37	FALSE	0	0
2026-12-18	2.5	0.4	PUT	0	65	117.33	FALSE	0	0
2026-12-18	5	0.75	PUT	0	2	96.14	FALSE	0	0
2026-12-18	7.5	1.32	PUT	0	164	107.98	FALSE	0	0
2026-12-18	10	2.53	PUT	0	272	89.54	FALSE	0	0
2026-12-18	12.5	4.8	PUT	0	313	93.11	TRUE	0	0
2026-12-18	15	8.52	PUT	0	188	103.22	TRUE	0	0
2026-12-18	17.5	8.93	PUT	0	4	105.86	TRUE	0	0
2026-12-18	20	9.8	PUT	0	100	106.06	TRUE	0	0
2026-12-18	22.5	0	PUT	0	22	106.99	TRUE	0	0
2026-12-18	25	16	PUT	0	8	102.19	TRUE	0	0
2026-12-18	27.5	0	PUT	0	0	108.71	TRUE	0	0
2026-12-18	30	22.56	PUT	0	330	105.6	TRUE	0	0
2026-12-18	32.5	0	PUT	0	0	107.62	TRUE	0	0
2026-12-18	35	0	PUT	0	5	110.74	TRUE	0	0
2026-12-18	37.5	0	PUT	0	0	103.63	TRUE	0	0
2026-12-18	40	32.3	PUT	0	30	105.46	TRUE	0	0
2026-12-18	42.5	0	PUT	0	0	115.7	TRUE	0	0
2026-12-18	45	0	PUT	0	0	104.41	TRUE	0	0
2026-12-18	47.5	0	PUT	0	0	0	TRUE	0	0
2026-12-18	50	0	PUT	0	0	0	TRUE	0	0
2026-12-18	52.5	0	PUT	0	0	0	TRUE	0	0
2026-12-18	55	0	PUT	0	0	0	TRUE	0	0
2026-12-18	57.5	0	PUT	0	0	0	TRUE	0	0
2026-12-18	60	0	PUT	0	0	0	TRUE	0	0
2026-12-18	65	0	PUT	0	0	0	TRUE	0	0
2027-01-15	2.5	9.4	CALL	0	53	133.59	TRUE	0	0
2027-01-15	5	9.3	CALL	0	63	109.52	TRUE	0	0
2027-01-15	7.5	7.6	CALL	0	39	108.63	TRUE	0	0
2027-01-15	10	4.9	CALL	0	684	107.99	TRUE	0	0
2027-01-15	12.5	3.91	CALL	0	258	100.71	FALSE	0	0
2027-01-15	15	3.79	CALL	13	4348	118.63	FALSE	3.79	0
2027-01-15	17.5	3.2	CALL	0	73	110.81	FALSE	0	0
2027-01-15	20	2.47	CALL	1	83	106.39	FALSE	-0.03	-0.01
2027-01-15	22.5	0	CALL	0	3	116.34	FALSE	0	0
2027-01-15	25	2.9	CALL	0	41	119.05	FALSE	0	0
2027-01-15	27.5	2	CALL	0	457	118.46	FALSE	0	0
2027-01-15	30	1.79	CALL	13	3781	113.67	FALSE	1.79	0
2027-01-15	32.5	1.42	CALL	0	8	116.29	FALSE	0	0
2027-01-15	35	1.56	CALL	0	5	129.07	FALSE	0	0
2027-01-15	37.5	0	CALL	0	0	132.64	FALSE	0	0
2027-01-15	40	1.2	CALL	0	135	139.66	FALSE	0	0
2027-01-15	42.5	1.46	CALL	0	50	137.67	FALSE	0	0
2027-01-15	45	2	CALL	0	8	139.19	FALSE	0	0
2027-01-15	47.5	0	CALL	0	0	141.81	FALSE	0	0
2027-01-15	50	0.8	CALL	0	11	144.25	FALSE	0	0
2027-01-15	52.5	0	CALL	0	0	146.55	FALSE	0	0
2027-01-15	55	1.4	CALL	0	1	147.42	FALSE	0	0
2027-01-15	57.5	0.05	CALL	0	1	149.47	FALSE	0	0
2027-01-15	60	2.05	CALL	0	6	151.41	FALSE	0	0
2027-01-15	65	0.74	CALL	0	11	155.67	FALSE	0	0
2027-01-15	2.5	0.45	PUT	0	14	132.52	FALSE	0	0
2027-01-15	5	0.9	PUT	0	3	146.58	FALSE	0	0
2027-01-15	7.5	1.7	PUT	0	40	109.18	FALSE	0	0
2027-01-15	10	3.3	PUT	0	303	89.66	FALSE	0	0
2027-01-15	12.5	5	PUT	0	5	102.38	TRUE	0	0
2027-01-15	15	6.7	PUT	0	230	105.61	TRUE	0	0
2027-01-15	17.5	8.8	PUT	0	13	106.95	TRUE	0	0
2027-01-15	20	10.1	PUT	0	115	108.48	TRUE	0	0
2027-01-15	22.5	14.9	PUT	0	3	109.58	TRUE	0	0
2027-01-15	25	0	PUT	0	8	104.17	TRUE	0	0
2027-01-15	27.5	0	PUT	0	0	103.77	TRUE	0	0
2027-01-15	30	0	PUT	0	4	102.26	TRUE	0	0
2027-01-15	32.5	0	PUT	0	0	101.03	TRUE	0	0
2027-01-15	35	22	PUT	0	2	103.97	TRUE	0	0
2027-01-15	37.5	24.85	PUT	0	30	108.25	TRUE	0	0
2027-01-15	40	30.09	PUT	0	10	115.7	TRUE	0	0
2027-01-15	42.5	0	PUT	0	1	115.97	TRUE	0	0
2027-01-15	45	0	PUT	0	0	101.61	TRUE	0	0
2027-01-15	47.5	0	PUT	0	0	0	TRUE	0	0
2027-01-15	50	0	PUT	0	0	98.84	TRUE	0	0
2027-01-15	52.5	0	PUT	0	0	0	TRUE	0	0
2027-01-15	55	0	PUT	0	0	104.54	TRUE	0	0
2027-01-15	57.5	0	PUT	0	0	0	TRUE	0	0
2027-01-15	60	0	PUT	0	0	0	TRUE	0	0
2027-01-15	65	0	PUT	0	0	0	TRUE	0	0
2028-01-21	2.5	11.5	CALL	0	466	128	TRUE	0	0
2028-01-21	5	10	CALL	0	124	120.99	TRUE	0	0
2028-01-21	7.5	8.57	CALL	0	480	123.65	TRUE	0	0
2028-01-21	10	6.5	CALL	0	727	101.91	TRUE	0	0
2028-01-21	12.5	5.8	CALL	0	70	106.48	FALSE	0	0
2028-01-21	15	4.89	CALL	0	321	111.5	FALSE	0	0
2028-01-21	17.5	6	CALL	0	17	97.18	FALSE	0	0
2028-01-21	20	5.6	CALL	0	99	94.6	FALSE	0	0
2028-01-21	22.5	4	CALL	0	6	92.58	FALSE	0	0
2028-01-21	25	4	CALL	0	55	88.68	FALSE	0	0
2028-01-21	27.5	4.96	CALL	0	25	100.89	FALSE	0	0
2028-01-21	30	3.25	CALL	0	118	90.14	FALSE	0	0
2028-01-21	32.5	0	CALL	0	0	93.2	FALSE	0	0
2028-01-21	35	2.75	CALL	0	132	91.72	FALSE	0	0
2028-01-21	2.5	0.8	PUT	0	11	132.79	FALSE	0	0
2028-01-21	5	0	PUT	0	0	130.37	FALSE	0	0
2028-01-21	7.5	2.95	PUT	0	8	105.01	FALSE	0	0
2028-01-21	10	4.8	PUT	3	779	104.56	FALSE	0.15	0.03
2028-01-21	12.5	5.67	PUT	0	1	102.85	TRUE	0	0
2028-01-21	15	7.72	PUT	0	11	98.52	TRUE	0	0
2028-01-21	17.5	12.42	PUT	0	1	96.71	TRUE	0	0
2028-01-21	20	11.87	PUT	0	0	97.34	TRUE	0	0
2028-01-21	22.5	0	PUT	0	0	95.22	TRUE	0	0
2028-01-21	25	0	PUT	0	0	92.3	TRUE	0	0
2028-01-21	27.5	0	PUT	0	0	88.62	TRUE	0	0
2028-01-21	30	0	PUT	0	0	93.14	TRUE	0	0
2028-01-21	32.5	0	PUT	0	0	89.81	TRUE	0	0
2028-01-21	35	27.45	PUT	0	10	91.63	TRUE	0	0

Latest BHVN Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	40	$143.84
Jun 13, 2022 7:59 PM EST	9	$143.84
Jun 13, 2022 7:59 PM EST	8	$143.87
Jun 13, 2022 7:59 PM EST	100	$143.87
Jun 13, 2022 7:59 PM EST	3	$143.83

Biohaven Pharmaceutical Holding Company Ltd (BHVN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2019-02-08	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000021545719006904/0000215457-19-006904-index.htm
2019-07-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000021545719008296/0000215457-19-008296-index.htm
2020-02-07	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000083423720008248/0000834237-20-008248-index.htm
2020-02-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000083423720009073/0000834237-20-009073-index.htm
2018-12-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465918071968/0001104659-18-071968-index.htm
2019-03-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465919015412/0001104659-19-015412-index.htm
2019-04-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465919020231/0001104659-19-020231-index.htm
2019-05-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465919027408/0001104659-19-027408-index.htm
2019-05-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465919027610/0001104659-19-027610-index.htm
2019-08-19	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000110465919046550/0001104659-19-046550-index.htm
2020-01-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465920003210/0001104659-20-003210-index.htm
2020-01-31	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465920009364/0001104659-20-009364-index.htm
2020-02-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465920027268/0001104659-20-027268-index.htm
2020-03-31	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465920041258/0001104659-20-041258-index.htm
2020-04-16	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1689813/000110465920047706/0001104659-20-047706-index.htm
2020-04-17	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000110465920047741/0001104659-20-047741-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000114420419008285/0001144204-19-008285-index.htm
2018-12-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-01-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-02-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010164/0001209191-19-010164-index.htm
2019-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010166/0001209191-19-010166-index.htm
2019-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010174/0001209191-19-010174-index.htm
2019-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010177/0001209191-19-010177-index.htm
2019-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010184/0001209191-19-010184-index.htm
2019-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010209/0001209191-19-010209-index.htm
2019-02-14	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010214/0001209191-19-010214-index.htm
2019-02-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-02-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-03-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-03-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-03-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-04-03	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119023434/0001209191-19-023434-index.htm
2019-04-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119023435/0001209191-19-023435-index.htm
2019-04-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-04-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2019-04-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2019-05-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119032463/0001209191-19-032463-index.htm
2019-05-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119032465/0001209191-19-032465-index.htm
2019-05-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119032466/0001209191-19-032466-index.htm
2019-05-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119032468/0001209191-19-032468-index.htm
2019-05-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119032470/0001209191-19-032470-index.htm
2019-05-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119032472/0001209191-19-032472-index.htm
2019-06-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-06-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2019-06-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2019-06-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2019-07-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039783/0001209191-19-039783-index.htm
2019-07-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039785/0001209191-19-039785-index.htm
2019-02-12	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000127417319000086/0001274173-19-000086-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000127417320000063/0001274173-20-000063-index.htm
2019-09-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000141057819001022/0001410578-19-001022-index.htm
2019-10-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000141057819001524/0001410578-19-001524-index.htm
2019-12-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-12-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218019006297/0001562180-19-006297-index.htm
2020-01-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-01-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2020-01-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-01-31	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000722/0001562180-20-000722-index.htm
2020-01-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000723/0001562180-20-000723-index.htm
2020-03-12	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020002440/0001562180-20-002440-index.htm
2020-04-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-05-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020003254/0001562180-20-003254-index.htm
2020-05-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020003255/0001562180-20-003255-index.htm
2020-05-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020003256/0001562180-20-003256-index.htm
2020-05-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020003257/0001562180-20-003257-index.htm
2020-05-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020003258/0001562180-20-003258-index.htm
2020-06-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004469/0001562180-20-004469-index.htm
2020-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004470/0001562180-20-004470-index.htm
2020-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-12	3/A	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004473/0001562180-20-004473-index.htm
2020-06-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-06-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2020-06-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-07-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-07-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-08-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-10-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-10-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2020-10-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-11-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-02-10	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000156223020000002/0001562230-20-000002-index.htm
2020-02-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000156223020000003/0001562230-20-000003-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1689813/000161577419002508/0001615774-19-002508-index.htm
2018-12-10	S-1	General form for registration of securities under the Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1689813/000162828018014980/0001628280-18-014980-index.htm
2018-12-10	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1689813/000162828018014982/0001628280-18-014982-index.htm
2018-12-10	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1689813/000162828018014985/0001628280-18-014985-index.htm
2018-12-12	S-1MEF	Registration adding securities to prior Form S-1 registration [Rule 462(b)]	https://www.sec.gov/Archives/edgar/data/1689813/000162828018015071/0001628280-18-015071-index.htm
2018-12-14	424B4	Prospectus [Rule 424(b)(4)]	https://www.sec.gov/Archives/edgar/data/1689813/000162828018015109/0001628280-18-015109-index.htm
2019-06-17	S-3ASR	Automatic shelf registration statement of securities of well-known seasoned issuers	https://www.sec.gov/Archives/edgar/data/1689813/000162828019008046/0001628280-19-008046-index.htm
2019-06-18	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1689813/000162828019008061/0001628280-19-008061-index.htm
2019-06-20	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1689813/000162828019008196/0001628280-19-008196-index.htm
2019-06-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000162828019008232/0001628280-19-008232-index.htm
2020-01-28	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1689813/000162828020000632/0001628280-20-000632-index.htm
2020-01-30	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1689813/000162828020000742/0001628280-20-000742-index.htm
2020-01-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000162828020000788/0001628280-20-000788-index.htm
2018-12-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981318000042/0001689813-18-000042-index.htm
2018-12-21	424B3	Prospectus [Rule 424(b)(3)]	https://www.sec.gov/Archives/edgar/data/1689813/000168981318000047/0001689813-18-000047-index.htm
2018-12-21	424B3	Prospectus [Rule 424(b)(3)]	https://www.sec.gov/Archives/edgar/data/1689813/000168981318000049/0001689813-18-000049-index.htm
2019-02-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000010/0001689813-19-000010-index.htm
2019-02-28	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000014/0001689813-19-000014-index.htm
2019-04-11	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000020/0001689813-19-000020-index.htm
2019-04-11	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000022/0001689813-19-000022-index.htm
2019-05-01	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000026/0001689813-19-000026-index.htm
2019-05-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000030/0001689813-19-000030-index.htm
2019-05-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000034/0001689813-19-000034-index.htm
2019-05-22	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000044/0001689813-19-000044-index.htm
2019-08-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000046/0001689813-19-000046-index.htm
2019-08-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000052/0001689813-19-000052-index.htm
2019-08-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000055/0001689813-19-000055-index.htm
2019-08-09	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000056/0001689813-19-000056-index.htm
2019-08-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2019-09-13	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-09-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000066/0001689813-19-000066-index.htm
2019-10-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-11-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000088/0001689813-19-000088-index.htm
2019-11-01	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000089/0001689813-19-000089-index.htm
2019-11-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000106/0001689813-19-000106-index.htm
2019-11-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000107/0001689813-19-000107-index.htm
2019-11-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000108/0001689813-19-000108-index.htm
2019-11-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000109/0001689813-19-000109-index.htm
2019-11-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000110/0001689813-19-000110-index.htm
2019-11-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000111/0001689813-19-000111-index.htm
2019-11-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000112/0001689813-19-000112-index.htm
2019-11-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000113/0001689813-19-000113-index.htm
2019-12-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000130/0001689813-19-000130-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2019-12-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-02-26	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000014/0001689813-20-000014-index.htm
2020-02-26	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000016/0001689813-20-000016-index.htm
2020-03-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000022/0001689813-20-000022-index.htm
2020-03-20	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000027/0001689813-20-000027-index.htm
2020-04-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000030/0001689813-20-000030-index.htm
2020-05-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000040/0001689813-20-000040-index.htm
2020-05-07	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000042/0001689813-20-000042-index.htm
2020-05-19	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000044/0001689813-20-000044-index.htm
2020-06-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000046/0001689813-20-000046-index.htm
2020-06-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000049/0001689813-20-000049-index.htm
2020-08-10	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000053/0001689813-20-000053-index.htm
2020-08-10	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000057/0001689813-20-000057-index.htm
2020-08-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1689813/000168981320000063/0001689813-20-000063-index.htm
2018-12-12	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1689813/999999999518003115/9999999995-18-003115-index.htm

Biohaven Pharmaceutical Holding Company Ltd (BHVN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biohaven Pharmaceutical Holding Company Ltd (BHVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1379%
Institutional Ownership: 11755%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2019-10-15	Elyse Stock	Chief Medical Officer	Sell	800.00	45.01	36,008.00	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2019-10-18	Elyse Stock	Chief Medical Officer	Sell	17,700.00	45.07	797,749.62	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2019-02-04	ERIC AGUIAR	Director	Sell	17,609.00	42.54	749,086.86	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11	ERIC AGUIAR	Director	Sell	10,000.00	45.00	450,000.00	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-11-20	ERIC AGUIAR	Director	Sell	6,729.00	52.20	351,234.29	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-11-22	ERIC AGUIAR	Director	Sell	1,250.00	55.24	69,050.00	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-09	ERIC AGUIAR	Director	Sell	4,072.00	55.11	224,410.77	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-16	ERIC AGUIAR	Director	Sell	3,537.00	55.13	194,984.55	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2019-01-10	John Tilton	Chief Commercial Officer	Sell	10,500.00	37.67	395,535.00	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-12	John Tilton	Chief Commercial Officer	Sell	10,000.00	50.11	501,100.00	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-02-21	JULIA P GREGORY	Director	Sell	12,000.00	43.56	522,720.00	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22	JULIA P GREGORY	Director	Sell	12,000.00	54.75	656,956.80	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-20	Kimberly Gentile	SVP, Clinical Operations	Sell	3,935.00	53.03	208,665.18	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-11-21	Kimberly Gentile	SVP, Clinical Operations	Sell	21,065.00	53.04	1,117,205.45	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-01-09	ERIC AGUIAR	Director	Sell	30,000.00	56.39	1,691,700.00	0.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2019-02-04	ERIC AGUIAR	Director	Buy	10,000.00	25.51	255,100.00	10,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-09-11	ERIC AGUIAR	Director	Buy	10,000.00	25.51	255,100.00	10,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000063/0001689813-19-000063-index.htm
2019-03-12	John Tilton	Chief Commercial Officer	Buy	10,000.00	9.29	92,900.00	10,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019524/0001209191-19-019524-index.htm
2019-06-26	JOHN W CHILDS	Director	Buy	10,000.00	40.37	403,700.00	10,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039192/0001209191-19-039192-index.htm
2019-03-26	Declan Doogan	Director	Sell	5,824.00	53.72	312,865.28	1,014,827.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-22	Declan Doogan	Director	Sell	5,351.00	53.66	287,134.66	1,020,651.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119021354/0001209191-19-021354-index.htm
2019-03-01	Declan Doogan	Director	Sell	50,000.00	47.19	2,359,500.00	1,026,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-01-10	John Tilton	Chief Commercial Officer	Buy	10,500.00	9.29	97,545.00	10,500.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119003595/0001209191-19-003595-index.htm
2019-03-22	JOHN W CHILDS	Director	Buy	107,500.00	9.29	998,675.00	107,500.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119023859/0001209191-19-023859-index.htm
2019-03-01	Declan Doogan	Director	Sell	595.00	45.41	27,018.95	1,076,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-27	Declan Doogan	Director	Sell	23,384.00	45.71	1,068,882.64	1,076,597.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18	Vlad Coric	Chief Executive Officer	Buy	10,950.00			10,950.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000128/0001689813-19-000128-index.htm
2019-02-25	Declan Doogan	Director	Sell	13,943.00	45.49	634,267.07	1,099,981.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-19	Declan Doogan	Director	Sell	1,400.00	45.51	63,714.00	1,113,924.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-15	Declan Doogan	Director	Sell	678.00	45.42	30,794.76	1,115,324.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119011732/0001209191-19-011732-index.htm
2019-02-13	Declan Doogan	Director	Sell	6,158.00	44.24	272,429.92	1,116,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2019-02-12	Declan Doogan	Director	Sell	33,842.00	44.32	1,499,877.44	1,122,160.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119010219/0001209191-19-010219-index.htm
2018-12-03	Declan Doogan	Director	Sell	40,000.00	41.95	1,678,000.00	1,156,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919118061265/0001209191-18-061265-index.htm
2019-02-21	JULIA P GREGORY	Director	Buy	12,000.00	23.63	283,560.00	12,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119012998/0001209191-19-012998-index.htm
2019-11-22	JULIA P GREGORY	Director	Buy	12,000.00	23.63	283,560.00	12,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000095/0001689813-19-000095-index.htm
2019-11-22	ERIC AGUIAR	Director	Buy	1,250.00	37.54	46,925.00	1,250.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2019-12-18	John Tilton	CCO-Rare & Neurologic Disorder	Buy	1,250.00			1,250.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000133/0001689813-19-000133-index.htm
2020-01-08	ERIC AGUIAR	Director	Buy	1,250.00	55.91	69,887.50	1,250.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-01-22	ERIC AGUIAR	Director	Sell	150.00	58.86	8,828.60	1,250.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-12-30	Robert Berman	Special Projects & Med Ovrsght	Buy	125,000.00	0.61	76,250.00	125,341.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-12	Elyse Stock	Chief Medical Officer	Sell	15,925.00	64.89	1,033,347.77	13,234.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19	Robert Berman	Special Projects & Med Ovrsght	Buy	986.00	0.61	601.46	1,327.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-11	James Engelhart	Chief Financial Officer	Sell	4,847.00	63.19	306,286.29	13,475.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22	ERIC AGUIAR	Director	Sell	200.00	58.00	11,599.00	1,400.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10	James Engelhart	Chief Financial Officer	Buy	11,453.00	9.29	106,398.37	15,975.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-01-22	ERIC AGUIAR	Director	Sell	671.00	56.99	38,243.18	1,600.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-18	Robert Berman	Special Projects & Med Ovrsght	Sell	59,914.00	75.25	4,508,822.08	1,741.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-11-02	WILLIAM A JR JONES	CCO-Migraine & Common Disease	Sell	1,300.00	77.70	101,005.06	1,755.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2019-02-04	ERIC AGUIAR	Director	Buy	7,609.00	20.79	158,191.11	17,609.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119007869/0001209191-19-007869-index.htm
2019-10-18	Elyse Stock	Chief Medical Officer	Buy	17,700.00	10.82	191,514.00	17,700.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000071/0001689813-19-000071-index.htm
2020-06-11	James Engelhart	Chief Financial Officer	Sell	5,972.00	62.07	370,697.57	18,322.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-12	Elyse Stock	Chief Medical Officer	Sell	11,390.00	65.80	749,497.31	1,844.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-06-26	Vlad Coric	Chief Executive Officer	Buy	5,000.00	40.22	201,100.00	19,130.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039193/0001209191-19-039193-index.htm
2020-01-22	ERIC AGUIAR	Director	Buy	771.00	32.42	24,995.82	2,021.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-11-21	Kimberly Gentile	SVP, Clinical Operations	Buy	21,065.00	0.61	12,849.65	21,065.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2020-10-08	Kimberly Gentile	SVP, Clinical Operations	Sell	5,261.00	75.62	397,843.66	21,878.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-12	Elyse Stock	Chief Medical Officer	Buy	20,716.00	20.79	430,685.64	22,560.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-01-22	ERIC AGUIAR	Director	Sell	500.00	55.99	27,995.50	2,271.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2019-06-27	Robert Berman	Chief Medical Officer	Buy	2,500.00	42.30	105,750.00	240,500.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039411/0001209191-19-039411-index.htm
2020-06-11	James Engelhart	Chief Financial Officer	Buy	19,772.00	9.29	183,681.88	24,294.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-04-07	JOHN W CHILDS	Director	Sell	14,734.00	33.26	490,119.14	2,476,938.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-08-11	JOHN W CHILDS	Director	Buy	2,600.00	60.32	156,823.94	2,479,538.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-08-11	JOHN W CHILDS	Director	Buy	7,271.00	61.28	445,567.61	2,486,809.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-04-07	JOHN W CHILDS	Director	Sell	93,268.00	32.92	3,070,130.74	2,491,672.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2019-06-27	James Engelhart	Chief Financial Officer	Buy	2,500.00	43.05	107,625.00	2,500.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119039412/0001209191-19-039412-index.htm
2020-08-11	JOHN W CHILDS	Director	Buy	15,129.00	61.87	936,093.26	2,501,938.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005409/0001562180-20-005409-index.htm
2020-09-11	JOHN W CHILDS	Director	Buy	6,678.00	59.00	393,983.97	2,508,616.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005986/0001562180-20-005986-index.htm
2020-09-21	JOHN W CHILDS	Director	Buy	3,322.00	59.25	196,828.50	2,511,938.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006075/0001562180-20-006075-index.htm
2020-10-23	Gregory Bailey	Director	Sell	212.00	79.94	16,948.00	2,545,658.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-23	Gregory Bailey	Director	Sell	10,191.00	78.89	803,918.05	2,545,870.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22	Gregory Bailey	Director	Sell	3,100.00	79.88	247,632.03	2,556,061.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-22	Gregory Bailey	Director	Sell	21,466.00	79.41	1,704,720.24	2,559,161.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006429/0001562180-20-006429-index.htm
2020-10-19	Gregory Bailey	Director	Sell	4,554.00	78.98	359,655.34	2,580,627.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-03-25	Gregory Bailey	Director	Buy	107,500.00	9.29	998,675.00	2,582,601.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119023860/0001209191-19-023860-index.htm
2020-04-07	JOHN W CHILDS	Director	Sell	10,908.00	31.55	344,196.49	2,584,940.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-10-16	Gregory Bailey	Director	Sell	3,748.00	78.88	295,638.12	2,585,181.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006406/0001562180-20-006406-index.htm
2019-08-20	Gregory Bailey	Director	Buy	5,000.00	37.65	188,250.00	2,587,601.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000061/0001689813-19-000061-index.htm
2020-10-12	Gregory Bailey	Director	Sell	6,729.00	78.87	530,740.45	2,588,929.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006368/0001562180-20-006368-index.htm
2020-07-08	Gregory Bailey	Director	Sell	5,991.00	75.93	454,888.24	2,595,658.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-04-07	JOHN W CHILDS	Director	Sell	81,090.00	30.54	2,476,585.91	2,595,848.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-07-08	Gregory Bailey	Director	Sell	44,009.00	75.12	3,305,876.86	2,601,649.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005101/0001562180-20-005101-index.htm
2020-06-24	Gregory Bailey	Director	Sell	2,395.00	70.24	168,224.80	2,645,658.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-24	Gregory Bailey	Director	Sell	1,600.00	69.29	110,864.96	2,648,053.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23	Gregory Bailey	Director	Sell	835.00	75.18	62,779.31	2,649,653.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-23	Gregory Bailey	Director	Sell	63,257.00	74.60	4,719,256.86	2,650,488.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-04-06	JOHN W CHILDS	Director	Sell	5,341.00	31.76	169,626.96	2,676,938.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-04-06	JOHN W CHILDS	Director	Sell	144,659.00	31.23	4,517,309.99	2,682,279.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020002967/0001562180-20-002967-index.htm
2020-06-23	Gregory Bailey	Director	Sell	24,084.00	73.72	1,775,368.92	2,713,745.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-10-08	Kimberly Gentile	SVP, Clinical Operations	Buy	23,500.00	9.29	218,315.00	27,139.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-23	Gregory Bailey	Director	Sell	13,467.00	72.70	979,026.66	2,737,829.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004698/0001562180-20-004698-index.htm
2020-06-22	Gregory Bailey	Director	Sell	49,132.00	73.64	3,618,011.70	2,751,296.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-17	Kimberly Gentile	SVP, Clinical Operations	Buy	24,000.00	5.60	134,400.00	27,639.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-01-22	ERIC AGUIAR	Director	Sell	500.00	54.97	27,485.85	2,771.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-05	Gregory Bailey	Director	Buy	212,500.00	0.61	129,625.00	2,800,101.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-22	Gregory Bailey	Director	Sell	20,659.00	72.91	1,506,202.24	2,800,428.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-22	Gregory Bailey	Director	Sell	10,540.00	72.01	758,961.16	2,821,087.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19	Gregory Bailey	Director	Sell	428.00	75.22	32,193.39	2,831,627.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19	Gregory Bailey	Director	Sell	22,584.00	73.78	1,666,267.85	2,832,055.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19	Gregory Bailey	Director	Sell	12,157.00	72.93	886,618.52	2,854,639.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19	Gregory Bailey	Director	Sell	21,798.00	71.98	1,568,935.03	2,866,796.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-19	Gregory Bailey	Director	Sell	58,238.00	70.91	4,129,854.59	2,888,594.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-12	Elyse Stock	Chief Medical Officer	Sell	5,300.00	64.05	339,448.04	29,159.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2020-06-19	Gregory Bailey	Director	Sell	26,814.00	70.10	1,879,792.79	2,946,832.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05	Gregory Bailey	Director	Buy	150,000.00	5.60	840,000.00	2,950,101.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-10	James Engelhart	Chief Financial Officer	Sell	28,821.00	66.66	1,921,135.81	29,654.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-19	Gregory Bailey	Director	Sell	22,012.00	69.01	1,519,094.35	2,973,646.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004629/0001562180-20-004629-index.htm
2020-06-05	Gregory Bailey	Director	Buy	37,700.00	9.29	350,233.00	2,987,801.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2019-12-18	WILLIAM A JR JONES	CCO-Migraine & Common Disease	Buy	3,000.00			3,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000132/0001689813-19-000132-index.htm
2020-01-09	ERIC AGUIAR	Director	Buy	30,000.00	9.29	278,700.00	30,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000347/0001562180-20-000347-index.htm
2020-06-05	Gregory Bailey	Director	Buy	20,000.00	10.82	216,400.00	3,007,801.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-06-05	Gregory Bailey	Director	Buy	18,000.00	28.76	517,680.00	3,025,801.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004321/0001562180-20-004321-index.htm
2020-01-09	Kimberly Gentile	SVP, Clinical Operations	Buy	1,000.00	37.54	37,540.00	3,049.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-11-02	WILLIAM A JR JONES	CCO-Migraine & Common Disease	Sell	4,010.00	77.01	308,799.27	3,055.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-07-08	Robert Berman	Special Projects & Med Ovrsght	Sell	55,626.00	75.25	4,185,745.25	3,119.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-10	John Tilton	Chief Commercial Officer	Sell	21,364.00	66.70	1,425,036.48	31,406.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-11-02	WILLIAM A JR JONES	CCO-Migraine & Common Disease	Buy	30,000.00	50.72	1,521,600.00	31,755.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-10	John Tilton	Chief Commercial Officer	Sell	5,331.00	68.57	365,528.01	3,237.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-01-22	ERIC AGUIAR	Director	Buy	1,250.00	37.54	46,925.00	3,271.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000570/0001562180-20-000570-index.htm
2020-06-10	James Engelhart	Chief Financial Officer	Buy	17,500.00	0.61	10,675.00	33,475.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18	Elyse Stock	Chief Medical Officer	Buy	3,375.00			3,375.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000134/0001689813-19-000134-index.htm
2019-12-30	Robert Berman	Special Projects & Med Ovrsght	Sell	300.00	55.97	16,791.00	341.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-18	Robert Berman	Special Projects & Med Ovrsght	Sell	1,400.00	76.05	106,467.48	341.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-19	Robert Berman	Special Projects & Med Ovrsght	Sell	986.00	75.07	74,015.96	341.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2020-06-23	Robert Berman	Special Projects & Med Ovrsght	Sell	4,296.00	75.05	322,431.12	341.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2020-07-08	Robert Berman	Special Projects & Med Ovrsght	Sell	2,778.00	75.29	209,144.51	341.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-06-12	Elyse Stock	Chief Medical Officer	Sell	4,351.00	63.02	274,208.72	34,459.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-12-16	ERIC AGUIAR	Director	Buy	3,537.00	20.79	73,534.23	3,537.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000118/0001689813-19-000118-index.htm
2020-01-09	Kimberly Gentile	SVP, Clinical Operations	Buy	590.00	20.79	12,266.10	3,639.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000345/0001562180-20-000345-index.htm
2020-06-08	Kimberly Gentile	SVP, Clinical Operations	Sell	600.00	70.05	42,027.48	3,639.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2020-06-17	Kimberly Gentile	SVP, Clinical Operations	Sell	24,000.00	70.20	1,684,869.60	3,639.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004575/0001562180-20-004575-index.htm
2020-10-08	Kimberly Gentile	SVP, Clinical Operations	Sell	2,458.00	77.42	190,300.08	3,639.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18	Robert Berman	Special Projects & Med Ovrsght	Buy	36,314.00	0.61	22,151.54	36,655.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-02-27	Declan Doogan	Director	Sell	1,900.00	45.86	87,134.00	373,913.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-12-18	Kimberly Gentile	SVP, Clinical Operations	Buy	3,750.00			3,750.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000131/0001689813-19-000131-index.htm
2019-02-27	Declan Doogan	Director	Sell	18,270.00	45.25	826,717.50	375,813.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2020-06-12	Elyse Stock	Chief Medical Officer	Buy	16,250.00	32.42	526,825.00	38,810.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004472/0001562180-20-004472-index.htm
2019-11-20	Kimberly Gentile	SVP, Clinical Operations	Buy	3,935.00	0.61	2,400.35	3,935.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000096/0001689813-19-000096-index.htm
2019-02-27	Declan Doogan	Director	Sell	6,875.00	44.17	303,668.75	394,083.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119015151/0001209191-19-015151-index.htm
2019-02-26	Declan Doogan	Director	Sell	100.00	44.81	4,481.00	400,958.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-26	Declan Doogan	Director	Sell	20,796.00	44.31	921,470.76	401,058.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-17	Kimberly Gentile	SVP, Clinical Operations	Buy	400.00	5.60	2,240.00	4,039.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004603/0001562180-20-004603-index.htm
2019-12-09	ERIC AGUIAR	Director	Buy	4,072.00	20.79	84,656.88	4,072.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000116/0001689813-19-000116-index.htm
2019-12-30	Robert Berman	Special Projects & Med Ovrsght	Sell	53,762.00	53.43	2,872,449.90	4,129.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2019-02-25	Declan Doogan	Director	Sell	100.00	45.74	4,574.00	421,854.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2019-02-25	Declan Doogan	Director	Sell	20,334.00	45.25	920,113.50	421,954.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-08	Kimberly Gentile	SVP, Clinical Operations	Buy	600.00	5.60	3,360.00	4,239.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004419/0001562180-20-004419-index.htm
2019-03-14	Vlad Coric	Chief Executive Officer	Sell	15,783.00	50.03	789,623.49	440,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22	Declan Doogan	Director	Sell	16,050.00	44.97	721,768.50	442,288.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-10	James Engelhart	Chief Financial Officer	Sell	300.00	68.07	20,420.01	4,522.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-06-11	James Engelhart	Chief Financial Officer	Sell	2,452.00	64.85	159,015.39	4,522.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13	Vlad Coric	Chief Executive Officer	Sell	8,262.00	50.02	413,265.24	455,783.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-02-22	Declan Doogan	Director	Sell	5,575.00	44.11	245,913.25	458,338.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119013671/0001209191-19-013671-index.htm
2020-06-23	Robert Berman	Special Projects & Med Ovrsght	Buy	4,296.00	0.61	2,620.56	4,637.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004697/0001562180-20-004697-index.htm
2019-03-12	Vlad Coric	Chief Executive Officer	Sell	25,955.00	50.15	1,301,643.25	464,045.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-14	Vlad Coric	Chief Executive Officer	Sell	16,110.00	50.02	805,822.20	475,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10	James Engelhart	Chief Financial Officer	Sell	24,832.00	67.53	1,676,989.39	4,822.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-03-13	Vlad Coric	Chief Executive Officer	Sell	7,883.00	50.02	394,307.66	491,110.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2019-03-12	Vlad Coric	Chief Executive Officer	Sell	26,007.00	50.15	1,304,251.05	498,993.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119019521/0001209191-19-019521-index.htm
2020-06-10	John Tilton	Chief Commercial Officer	Buy	52,000.00	9.29	483,080.00	52,770.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2019-12-30	Robert Berman	Special Projects & Med Ovrsght	Sell	67,450.00	52.95	3,571,349.35	57,891.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-10	James Engelhart	Chief Financial Officer	Buy	25,000.00	5.60	140,000.00	58,475.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2020-07-08	Robert Berman	Special Projects & Med Ovrsght	Buy	58,404.00	0.61	35,626.44	58,745.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020005100/0001562180-20-005100-index.htm
2020-10-08	Kimberly Gentile	SVP, Clinical Operations	Sell	15,781.00	76.42	1,205,938.26	6,097.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006335/0001562180-20-006335-index.htm
2020-06-18	Robert Berman	Special Projects & Med Ovrsght	Buy	25,000.00	5.60	140,000.00	61,655.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004627/0001562180-20-004627-index.htm
2019-12-18	James Engelhart	Chief Financial Officer	Buy	3,700.00			6,200.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000129/0001689813-19-000129-index.htm
2019-12-18	Robert Berman	Special Projects & Med Ovrsght	Buy	625.00			625.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000136/0001689813-19-000136-index.htm
2020-06-16	Declan Doogan	Director	Sell	300.00	69.42	20,825.01	626,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-16	Declan Doogan	Director	Sell	25,208.00	68.73	1,732,457.61	626,302.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-12-30	Robert Berman	Special Projects & Med Ovrsght	Sell	3,488.00	54.89	191,462.25	641.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218019006296/0001562180-19-006296-index.htm
2020-06-16	Declan Doogan	Director	Sell	31,920.00	67.90	2,167,514.83	651,510.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2019-11-20	ERIC AGUIAR	Director	Buy	6,729.00	32.42	218,154.18	6,729.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000097/0001689813-19-000097-index.htm
2020-06-16	Declan Doogan	Director	Sell	2,572.00	66.94	172,161.71	683,430.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15	Declan Doogan	Director	Sell	15,797.00	68.10	1,075,800.98	686,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-11	James Engelhart	Chief Financial Officer	Sell	6,501.00	64.31	418,057.86	6,974.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004453/0001562180-20-004453-index.htm
2019-12-18	Charles Conway	Chief Scientific Officer	Buy	3,000.00			7,000.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000135/0001689813-19-000135-index.htm
2020-06-15	Declan Doogan	Director	Sell	18,703.00	67.51	1,262,557.24	701,799.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-11-02	WILLIAM A JR JONES	CCO-Migraine & Common Disease	Sell	24,690.00	76.02	1,876,872.08	7,065.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020006560/0001562180-20-006560-index.htm
2020-06-15	Declan Doogan	Director	Sell	34,336.00	66.05	2,267,872.20	720,502.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-15	Declan Doogan	Director	Sell	11,164.00	65.62	732,560.47	754,838.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004574/0001562180-20-004574-index.htm
2020-06-12	Declan Doogan	Director	Sell	25,914.00	65.78	1,704,749.90	766,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10	John Tilton	Chief Commercial Officer	Sell	2,467.00	69.40	171,201.91	770.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-12	Declan Doogan	Director	Sell	28,086.00	64.79	1,819,683.51	791,916.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-10-15	Elyse Stock	Chief Medical Officer	Buy	800.00	10.82	8,656.00	800.00	https://www.sec.gov/Archives/edgar/data/1689813/000168981319000068/0001689813-19-000068-index.htm
2020-06-12	Declan Doogan	Director	Sell	18,400.00	63.90	1,175,767.36	820,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-12	Declan Doogan	Director	Sell	7,600.00	62.93	478,252.04	838,402.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11	Declan Doogan	Director	Sell	25,039.00	64.57	1,616,873.39	846,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-10	John Tilton	Chief Commercial Officer	Sell	22,838.00	67.53	1,542,234.15	8,568.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004454/0001562180-20-004454-index.htm
2020-06-11	Declan Doogan	Director	Sell	18,474.00	63.79	1,178,530.36	871,041.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11	Declan Doogan	Director	Sell	20,043.00	62.78	1,258,207.34	889,515.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2020-06-11	Declan Doogan	Director	Sell	16,444.00	61.97	1,018,988.64	909,558.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020004471/0001562180-20-004471-index.htm
2019-04-16	Declan Doogan	Director	Sell	50,000.00	61.92	3,096,000.00	926,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm
2020-01-08	Elyse Stock	Chief Medical Officer	Buy	937.00	55.91	52,387.67	937.00	https://www.sec.gov/Archives/edgar/data/1689813/000156218020000346/0001562180-20-000346-index.htm
2019-04-12	Declan Doogan	Director	Sell	38,825.00	53.92	2,093,444.00	976,002.00	https://www.sec.gov/Archives/edgar/data/1689813/000120919119024835/0001209191-19-024835-index.htm

Biohaven Pharmaceutical Holding Company Ltd

(NYSE:BHVN)